ResearcherStony Brook UniversityActive in the last 2 years

Emma Wen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5125580668. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic ductal adenocarcinoma spheroids and organo… Co-author DOI 10.3389/fphar.2026.1685433 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Joseph F. LaComb · 1 shared paper, 2026 · strength 0.29
- Paper AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic du… DOI 10.3389/fphar.2026.1685433 ↗
Fatim M. Kouassi · 1 shared paper, 2026 · strength 0.29
- Paper AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic du… DOI 10.3389/fphar.2026.1685433 ↗
Agnieszka Beata Bialkowska · 1 shared paper, 2026 · strength 0.29
- Paper AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic du… DOI 10.3389/fphar.2026.1685433 ↗
Antonio T. Baines · 1 shared paper, 2026 · strength 0.29
- Paper AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic du… DOI 10.3389/fphar.2026.1685433 ↗
David Arthur Tuveson · 1 shared paper, 2026 · strength 0.29
- Paper AUM-302, a novel triple PIM/PI3K/mTOR inhibitor, synergizes with RAS inhibition and impedes the growth of pancreatic du… DOI 10.3389/fphar.2026.1685433 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.